Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013)

Relmada Therapeutics (RLMD) reported Change in Inventory of -$1565.0 for Q4 2013, down 184.59% year-over-year from $1850.0 in Q4 2012, and down 95.62% quarter-over-quarter from -$800.0 in Q3 2013.

Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013) Analysis & Trends

Relmada Therapeutics (RLMD) has 2 years of Change in Inventory data on file, last reported at -$1565.0 in Q4 2013.

  • Change in Inventory for Q4 2013 came in at -$1565.0, down 184.59% year-over-year; the trailing twelve-month figure through Nov 2013 was -$179.0 (changed N/A YoY), and the FY2013 annual result was $3236.0, up 559.06% from the prior year.
  • Change in Inventory eased to -$1565.0 in Q4 2013 per RLMD's latest filing, from -$800.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $1865.0 in Q1 2013 and troughed at -$1565.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 51,468.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 97.70 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Relmada Therapeutics 581.07 Mn 581.07 Mn - -

Historic Data

Download Data
DateValue
Nov 30, 2013 -1,565.00
Nov 30, 2013 -1,565.00
Aug 31, 2013 -800.00
Aug 31, 2013 -800.00
May 31, 2013 321.00
May 31, 2013 321.00
Feb 28, 2013 1,865.00
Feb 28, 2013 1,865.00
Nov 30, 2012 1,850.00
Nov 30, 2012 1,850.00
Aug 31, 2012 1,348.00
Aug 31, 2012 1,348.00
May 31, 2012 678.00
May 31, 2012 678.00